<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00200785</url>
  </required_header>
  <id_info>
    <org_study_id>R21AT001512-01</org_study_id>
    <nct_id>NCT00200785</nct_id>
  </id_info>
  <brief_title>Identifying the Anti-Blood-Clotting Compounds in Garlic</brief_title>
  <official_title>Identification of the Antiplatelet Compounds of Garlic Ex Vivo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will seek to identify the compound(s) in garlic that is (are) responsible for its
      ability to prevent the formation of blood clots (prevent platelet aggregation) and to
      determine the maximally effective dose and duration of the benefits. This study will also
      determine whether &quot;cooked&quot; garlic (garlic powder added to boiling water, no allicin present)
      is as effective as &quot;fresh&quot; garlic (garlic powder added to ambient water, high allicin
      present) and, if more than one compound is involved, and whether their combined effects are
      more significant than the effects of each compound alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Published studies indicate that various types of undefined garlic products display
      antiplatelet activity. However, the compounds responsible for this antiplatelet effect have
      not been identified.

      Acute studies. In acute (one day) studies, healthy participants will consume several doses of
      &quot;fresh garlic&quot; (garlic powder added to ambient water; up to the equivalent of 12 grams fresh
      garlic or 52 mg allicin) as a paste in a tuna sandwich. At 0, 2, 4, and 6 hours after
      consumption, the ability of platelets to aggregate in platelet-rich plasma (PRP) or in whole
      blood (WB), in response to a drug (collagen, ADP) that stimulates platelet aggregation, will
      be measured. After establishing the optimum dose and optimum time of the antiplatelet effect
      for each person, and if the effects are sufficiently strong, the effects of cooked garlic
      (garlic powder added to boiling water, no allicin present) and seven extracted fractions
      (oil, protein, fructans, etc.) will be determined, using the fractions at the same dose as
      their abundance in the established optimum dose of crushed fresh garlic.

      Chronic studies. If only weak platelet effects are found for a high acute dose of &quot;fresh&quot;
      garlic, chronic studies will be conducted. In chronic studies, participants will consume 8.0
      grams of &quot;fresh garlic&quot; (2.7 grams garlic powder added to ambient water, allicin content = 35
      mg) as a paste in a tuna sandwich every day for four weeks and 8.0 grams of &quot;boiled garlic&quot;
      (2.7 grams garlic powder added to boiling water) in a sandwich every day for an additional
      four weeks, after a 1-week washout. The ability of platelets to aggregate in PRP and whole
      blood will be determined before and every week after garlic consumption begins and after the
      1-week washout.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Platelet Aggregation</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Electrical Impedance in Ohms</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Arteriosclerosis</condition>
  <condition>Intracranial Arteriosclerosis</condition>
  <arm_group>
    <arm_group_label>Garlic powder in ambient water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>high allicin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>garlic powder in boiling water</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>no allicin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>garlic powder added to ambient water</intervention_name>
    <description>consumed 2.7 grams of garlic powder added to ambient water (equivalent to 8 grams fresh or raw garlic) in a sandwich, once a day for four weeks</description>
    <arm_group_label>Garlic powder in ambient water</arm_group_label>
    <other_name>Global Marketing Assoc., Inc.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>garlic powder added to boiling water</intervention_name>
    <description>consumed 2.7 grams of garlic powder added to boiling water (equivalent to 8 grams of cooked garlic) in a sandwich, once a day for four weeks</description>
    <arm_group_label>garlic powder in boiling water</arm_group_label>
    <other_name>Global Marketing Assoc., Inc.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index of 19 to 30 kg/m2

          -  Plans to remain in the study area for the next year

          -  Willingness to abstain from nonsteroidal anti-inflammatory drugs (NSAID drugs for 1
             week prior to each study test

          -  Willingness to abstain from consuming garlic and significant amounts of onion,
             chocolate, or purple grape juice for 3 days prior to each study test

          -  Willingness to participate in all study tests

        Exclusion Criteria:

          -  Pregnancy or breast-feeding

          -  Serious medical condition

          -  Allergy to garlic or wheat

          -  Tobacco use

          -  Excessive alcohol consumption

          -  Under psychiatric care
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larry D. Lawson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Silliker, Inc./Plant Bioactives Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Silliker, Inc./Plant Bioactives Research Institute</name>
      <address>
        <city>Orem</city>
        <state>Utah</state>
        <zip>84058</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <results_first_submitted>April 23, 2009</results_first_submitted>
  <results_first_submitted_qc>December 4, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 11, 2010</results_first_posted>
  <last_update_submitted>December 4, 2009</last_update_submitted>
  <last_update_submitted_qc>December 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Larry D. Lawson principal investigator</name_title>
    <organization>Silliker, Inc./Plant Bioactives Research Institute, Inc.</organization>
  </responsible_party>
  <keyword>garlic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Intracranial Arteriosclerosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>healthy participants were recruited in Utah county, Utah, in early 2006</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Garlic Powder: High Allicin</title>
          <description>garlic powder in ambient water</description>
        </group>
        <group group_id="P2">
          <title>Garlic Powder: No Allicin</title>
          <description>garlic powder in boiling water</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout Period of 1 Week</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Garlic Powder: High Allicin</title>
          <description>garlic powder in ambient water</description>
        </group>
        <group group_id="B2">
          <title>Garlic Powder: No Allicin</title>
          <description>garlic powder in boiling water</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.2" spread="13.7"/>
                    <measurement group_id="B2" value="36.5" spread="15.1"/>
                    <measurement group_id="B3" value="32.2" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>electrical impedance (ohms) at 0 weeks</title>
          <description>collagen-induced platelet aggregation in whole blood (WB)</description>
          <units>ohms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.7" spread="1.2"/>
                    <measurement group_id="B2" value="15.0" spread="1.6"/>
                    <measurement group_id="B3" value="13.9" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>percent platelet aggregation at 0 weeks</title>
          <description>collagen-induced aggregation in platelet-rich plasma (PRP)</description>
          <units>percent platelet aggregation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76.0" spread="1.6"/>
                    <measurement group_id="B2" value="71.8" spread="5.7"/>
                    <measurement group_id="B3" value="73.9" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Platelet Aggregation</title>
        <description>percent platelet aggregation in collagen-induced platelet aggregation in platelet rich plasma (PRP)</description>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Garlic Powder: High Allicin</title>
            <description>garlic powder in ambient water</description>
          </group>
          <group group_id="O2">
            <title>Garlic Powder: No Allicin</title>
            <description>garlic powder in boiling water</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Platelet Aggregation</title>
          <description>percent platelet aggregation in collagen-induced platelet aggregation in platelet rich plasma (PRP)</description>
          <units>percent platelet aggregation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.4" spread="4.3"/>
                    <measurement group_id="O2" value="72.5" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Electrical Impedance in Ohms</title>
        <description>Electrical impedance (ohms) was measured using 0.5 mL of whole blood plus 0.5 mL saline in a Chronolog Whole Blood aggregometer. Ten mL of whole blood were collected and tested every week. There is no mathematical correlation between impedance (ohms) and percent aggregation.</description>
        <time_frame>4 weeks</time_frame>
        <population>Nine persons participated in the &quot;high allicin&quot; test. Six of the same persons participated in the &quot;no allicin&quot; test.</population>
        <group_list>
          <group group_id="O1">
            <title>Garlic Powder: High Allicin</title>
            <description>garlic powder in ambient water</description>
          </group>
          <group group_id="O2">
            <title>Garlic Powder: No Allicin</title>
            <description>garlic powder in boiling water</description>
          </group>
        </group_list>
        <measure>
          <title>Electrical Impedance in Ohms</title>
          <description>Electrical impedance (ohms) was measured using 0.5 mL of whole blood plus 0.5 mL saline in a Chronolog Whole Blood aggregometer. Ten mL of whole blood were collected and tested every week. There is no mathematical correlation between impedance (ohms) and percent aggregation.</description>
          <population>Nine persons participated in the &quot;high allicin&quot; test. Six of the same persons participated in the &quot;no allicin&quot; test.</population>
          <units>ohms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" spread="1.5"/>
                    <measurement group_id="O2" value="15.0" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Garlic Powder: High Allicin</title>
          <description>garlic powder in ambient water</description>
        </group>
        <group group_id="E2">
          <title>Garlic Powder: No Allicin</title>
          <description>garlic powder in boiling water</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Larry D. Lawson</name_or_title>
      <organization>Silliker, Inc./Plant Bioactives Research Institute, Inc.</organization>
      <phone>801-226-3041</phone>
      <email>larry.lawson@silliker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

